FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557217997> ?p ?o ?g. }

• W2557217997 abstract "Tyrpsine kinase inhibitors (TKIs) effectively target progenitors and mature leukaemic cells but prove less effective at eliminating leukaemic stem cells (LSCs) in patients with chronic myeloid leukaemia (CML). Several reports indicate that the TGFβ superfamily pathway is important for LSC survival and quiescence. We conducted extensive microarray analyses to compare expression patterns in normal haemopoietic stem cells (HSC) and progenitors with CML LSC and progenitor populations in chronic phase (CP), accelerated phase (AP) and blast crisis (BC) CML. The BMP/SMAD pathway and downstream signalling molecules were identified as significantly deregulated in all three phases of CML. The changes observed could potentiate altered autocrine signalling, as BMP2, BMP4 (p<0.05), and ACTIVIN A (p<0.001) were all down regulated, whereas BMP7, BMP10 and TGFβ (p<0.05) were up regulated in CP. This was accompanied by up regulation of BMPRI (p<0.05) and downstream SMADs (p<0.005). Interestingly, as CML progressed, the profile altered, with BC patients showing significant over-expression of ACTIVIN A and its receptor ACVR1C. To further characterise the BMP pathway and identify potential candidate biomarkers within a larger cohort, expression analysis of 42 genes in 60 newly diagnosed CP CML patient samples, enrolled on a phase III clinical trial (www.spirit-cml.org) with greater than 12 months follow-up data on their response to TKI was performed. Analysis revealed that the pathway was highly deregulated, with no clear distinction when patients were stratified into good, intermediate and poor response to treatment.One of the major issues in developing new treatments to target LSCs is the ability to test small molecule inhibitors effectively as it is difficult to obtain sufficient LSCs from primary patient material. Using reprogramming technologies, we generated induced pluripotent stem cells (iPSCs) from CP CML patients and normal donors. CML- and normal-derived iPSCs were differentiated along the mesodermal axis to generate haemopoietic and endothelial precursors (haemangioblasts). IPSC-derived haemangioblasts exhibited sensitivity to TKI treatment with increased apoptosis and reduction in the phosphorylation of downstream target proteins.4Dual inhibition studies were performed using BMP pathway inhibitors in combination with TKI on CML cell lines, primary cells and patient derived iPSCs. Results indicate that they act synergistically to target CML cells both in the presence and absence of BMP4 ligand. Inhibition resulted in decreased proliferation, irreversible cell cycle arrest, increased apoptosis, reduced haemopoietic colony formation, altered gene expression pattern, reduction in self-renewal and a significant reduction in the phosphorylation of downstream target proteins. These changes offer a therapeutic window in CML, with intervention using BMP inhibitors in combination with TKI having the potential to prevent LSC self-renewal and improve outcome for patients. By successfully developing and validating iPSCs for CML drug screening we hope to substantially reduce the reliance on animal models for early preclinical drug screening in leukaemia." @default.
• W2557217997 created "2016-11-30" @default.
• W2557217997 creator A5052132124 @default.
• W2557217997 date "2016-01-01" @default.
• W2557217997 modified "2023-09-24" @default.
• W2557217997 title "Using induced pluripotent stem cells (IPSCS) as a replacement for in vivo models to screen novel therapies in chronic myeloid leukaemia (CML)" @default.
• W2557217997 hasPublicationYear "2016" @default.
• W2557217997 type Work @default.
• W2557217997 sameAs 2557217997 @default.
• W2557217997 citedByCount "0" @default.
• W2557217997 crossrefType "dissertation" @default.
• W2557217997 hasAuthorship W2557217997A5052132124 @default.
• W2557217997 hasConcept C104317684 @default.
• W2557217997 hasConcept C107459253 @default.
• W2557217997 hasConcept C126322002 @default.
• W2557217997 hasConcept C128240485 @default.
• W2557217997 hasConcept C145103041 @default.
• W2557217997 hasConcept C170493617 @default.
• W2557217997 hasConcept C201750760 @default.
• W2557217997 hasConcept C203014093 @default.
• W2557217997 hasConcept C2779282312 @default.
• W2557217997 hasConcept C28328180 @default.
• W2557217997 hasConcept C502942594 @default.
• W2557217997 hasConcept C54355233 @default.
• W2557217997 hasConcept C71924100 @default.
• W2557217997 hasConcept C86803240 @default.
• W2557217997 hasConcept C95444343 @default.
• W2557217997 hasConceptScore W2557217997C104317684 @default.
• W2557217997 hasConceptScore W2557217997C107459253 @default.
• W2557217997 hasConceptScore W2557217997C126322002 @default.
• W2557217997 hasConceptScore W2557217997C128240485 @default.
• W2557217997 hasConceptScore W2557217997C145103041 @default.
• W2557217997 hasConceptScore W2557217997C170493617 @default.
• W2557217997 hasConceptScore W2557217997C201750760 @default.
• W2557217997 hasConceptScore W2557217997C203014093 @default.
• W2557217997 hasConceptScore W2557217997C2779282312 @default.
• W2557217997 hasConceptScore W2557217997C28328180 @default.
• W2557217997 hasConceptScore W2557217997C502942594 @default.
• W2557217997 hasConceptScore W2557217997C54355233 @default.
• W2557217997 hasConceptScore W2557217997C71924100 @default.
• W2557217997 hasConceptScore W2557217997C86803240 @default.
• W2557217997 hasConceptScore W2557217997C95444343 @default.
• W2557217997 hasLocation W25572179971 @default.
• W2557217997 hasOpenAccess W2557217997 @default.
• W2557217997 hasPrimaryLocation W25572179971 @default.
• W2557217997 hasRelatedWork W1812137864 @default.
• W2557217997 hasRelatedWork W1965619359 @default.
• W2557217997 hasRelatedWork W2073798076 @default.
• W2557217997 hasRelatedWork W2112862229 @default.
• W2557217997 hasRelatedWork W2177783313 @default.
• W2557217997 hasRelatedWork W2563829784 @default.
• W2557217997 hasRelatedWork W2567529851 @default.
• W2557217997 hasRelatedWork W2581401829 @default.
• W2557217997 hasRelatedWork W2590914352 @default.
• W2557217997 hasRelatedWork W2620808717 @default.
• W2557217997 hasRelatedWork W2741655581 @default.
• W2557217997 hasRelatedWork W2770731101 @default.
• W2557217997 hasRelatedWork W2775919407 @default.
• W2557217997 hasRelatedWork W2811155914 @default.
• W2557217997 hasRelatedWork W2891924810 @default.
• W2557217997 hasRelatedWork W2919016945 @default.
• W2557217997 hasRelatedWork W2955039457 @default.
• W2557217997 hasRelatedWork W3014258144 @default.
• W2557217997 hasRelatedWork W3129500415 @default.
• W2557217997 hasRelatedWork W3199794832 @default.
• W2557217997 isParatext "false" @default.
• W2557217997 isRetracted "false" @default.
• W2557217997 magId "2557217997" @default.
• W2557217997 workType "dissertation" @default.